1355483-74-7

Basic information

• Product Name: 2-(4-bromophenyl)-5,6,7-trimethoxy-4H-chromen-4-one
• Synonyms: 2-(4-bromophenyl)-5,6,7-trimethoxy-4H-chromen-4-one
• CAS NO: 1355483-74-7
• Molecular Weight: 391.218
• Mol File: 1355483-74-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 2-(4-bromophenyl)-5,6,7-trimethoxy-4H-chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-bromophenyl)-5,6,7-trimethoxy-4H-chromen-4-one(1355483-74-7)
• EPA Substance Registry System: 2-(4-bromophenyl)-5,6,7-trimethoxy-4H-chromen-4-one(1355483-74-7)

Safety Data

• Hazardous Substances Data: 1355483-74-7(Hazardous Substances Data)

Upstream product

• 1355483-83-8 C₁₈H₁₇BrO₅ 
• 13565-09-8 4-bromocinnamoyl chloride 
• 1200-07-3 3-(4-bromophenyl)acrylic acid 
• 1122-91-4 4-bromo-benzaldehyde 
• 17742-46-0 acetic acid 3,4,5-trimethoxy-phenyl ester 
• 642-71-7 3,4,5-trimethoxyphenol 
• 22248-14-2 6-hydroxy-2,3,4-trimethoxyacetophenone 

Downstream Products

• 1355483-79-2 2-(4-bromophenyl)-5,6,7-trihydroxy-4H-chromen-4-one 
• 1637569-02-8 2-(4-bromophenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one 
• 1637569-00-6 2-(4-bromophenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one 

Relevant articles and documents

Novel tacrine-scutellarin hybrids as multipotent anti-Alzheimer’s agents: Design, synthesis and biological evaluation

A novel series of 6-chlorotacrine-scutellarin hybrids was designed, synthesized and the biological activity as potential anti-Alzheimer’s agents was assessed. Their inhibitory activity towards human acetylcholinesterase (hAChE) and human butyrylcholineste

Baicalein derivative as well as preparation method and application thereof (by machine translation)

The invention discloses a baicalein derivative, structure as shown in the specification : In-flight, R1 A hydrogen, alkyl, is substituted or unsubstituted aryl ;R. 2 The hydrogen, halogen, alkyl, alkoxy, may be substituted or unsubst

Antibacterial Flavonoids from Medicinal Plants Covalently Inactivate Type III Protein Secretion Substrates

Traditional Chinese Medicines (TCMs) have been historically used to treat bacterial infections. However, the molecules responsible for these anti-infective properties and their potential mechanisms of action have remained elusive. Using a high-throughput